Published in Lancet on February 27, 1988
Pathophysiologic response to severe burn injury. Ann Surg (2008) 3.73
Long-term persistance of the pathophysiologic response to severe burn injury. PLoS One (2011) 2.58
Low-dose growth hormone and hypocaloric nutrition attenuate the protein-catabolic response after major operation. Ann Surg (1989) 1.37
Growth hormone treatment in pediatric burns: a safe therapeutic approach. Ann Surg (1998) 1.15
Total parenteral nutrition with glutamine dipeptide after major abdominal surgery: a randomized, double-blind, controlled study. Ann Surg (1998) 1.12
The effects of infusion of insulinlike growth factor (IGF) I, IGF-II, and insulin on glucose and protein metabolism in fasted lambs. J Clin Invest (1991) 0.99
Biosynthetic human growth hormone preserves both muscle protein synthesis and the decrease in muscle-free glutamine, and improves whole-body nitrogen economy after operation. Ann Surg (1992) 0.91
Effects of recombinant human growth hormone in patients with severe sepsis. Ann Surg (1992) 0.89
Protein-sparing effect in skeletal muscle of growth hormone treatment in critically ill patients. Ann Surg (2000) 0.89
Growth hormone and insulin reverse net whole body and skeletal muscle protein catabolism in cancer patients. Ann Surg (1992) 0.87
Growth hormone after abdominal surgery attenuated forearm glutamine, alanine, 3-methylhistidine, and total amino acid efflux in patients receiving total parenteral nutrition. Ann Surg (1993) 0.87
Perioperative growth hormone treatment and functional outcome after major abdominal surgery: a randomized, double-blind, controlled study. Ann Surg (1999) 0.82
Proper use of growth hormone. Arch Dis Child (1990) 0.79
Postoperative protein sparing with epidural analgesia and hypocaloric dextrose. Ann Surg (2004) 0.77
Clinical evidence of growth hormone for patients undergoing abdominal surgery: meta-analysis of randomized controlled trials. World J Gastroenterol (2005) 0.75
Effects of glutamine-containing total parenteral nutrition on phagocytic activity and anabolic hormone response in rats undergoing gastrectomy. World J Gastroenterol (2005) 0.75
Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet (2007) 2.91
Muscle protein synthesis measured by stable isotope techniques in man: the effects of feeding and fasting. Clin Sci (Lond) (1982) 2.53
Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix. N Engl J Med (1999) 2.17
Absence of dyspeptic symptoms as a test of Helicobacter pylori eradication. BMJ (1996) 1.98
Randomised controlled trials of immediate weight-bearing mobilisation for rupture of the tendo Achillis. J Bone Joint Surg Br (2006) 1.85
Diagnosis and treatment of granulomatous mastitis. Br J Surg (1995) 1.83
Radioimmunoassay of cannabinoids in blood and urine. Lancet (1974) 1.73
Decrease in human quadriceps muscle protein turnover consequent upon leg immobilization. Clin Sci (Lond) (1987) 1.65
Colonoscopy findings in symptomatic patients without X-ray evidence of colonic neoplasms. Lancet (1986) 1.65
Leucine incorporation into mixed skeletal muscle protein in humans. Am J Physiol (1988) 1.62
The economic and quality-of-life benefits of Helicobacter pylori eradication in chronic duodenal ulcer disease--a community-based study. Postgrad Med J (1995) 1.59
Effect of diazoxide or glucagon on hepatic glucose production rate during extreme neonatal hypoglycaemia. Arch Dis Child (1987) 1.53
Contribution of aminoacid catabolism to propionate production in methylmalonic acidaemia. Lancet (1989) 1.50
Glucose production by the human placenta in vivo. Placenta (1999) 1.42
Influence of glucagon on protein and leucine metabolism: a study in fasting man with induced insulin resistance. Br J Surg (1990) 1.41
Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands. J Med Genet (2008) 1.41
The prediction of total body water using bioelectrical impedance in children and adolescents. Ann Hum Biol (1988) 1.35
Effect of testosterone on muscle mass and muscle protein synthesis. J Appl Physiol (1985) (1989) 1.34
Measurement of muscle protein synthetic rate from serial muscle biopsies and total body protein turnover in man by continuous intravenous infusion of L-(alpha-15N)lysine. Clin Sci Mol Med (1975) 1.30
The development of a radioimmunoassay for cannabinoids in blood and urine. J Pharm Pharmacol (1975) 1.30
Effect of exercise on protein turnover in man. Clin Sci (Lond) (1981) 1.29
Absence of glutamine isotopic steady state: implications for the assessment of whole-body glutamine production rate. Clin Sci (Lond) (1998) 1.28
Effects of Duchenne muscular dystrophy on muscle protein synthesis. Nature (1982) 1.28
Resting metabolic rate, weight, surface area and body composition in obese women. Int J Obes (1979) 1.27
Protein synthesis in muscle measured in vivo in cachectic patients with cancer. Br Med J (Clin Res Ed) (1984) 1.26
Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system. Microsc Res Tech (2001) 1.25
Sources of propionate in inborn errors of propionate metabolism. Metabolism (1990) 1.25
Rapid measurement of whole body and forearm protein turnover using a [2H5]phenylalanine model. Am J Physiol (1989) 1.25
Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia (1983) 1.24
Glycosylated haemoglobin and glucose intolerance in cystic fibrosis. Arch Dis Child (1987) 1.23
Rubber band ligation versus haemorrhoidectomy for prolapsing haemorrhoids: a long term prospective clinical trial. Br J Surg (1982) 1.22
Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg (1987) 1.21
Increased energy expenditure in poorly controlled Type 1 (insulin-dependent) diabetic patients. Diabetologia (1984) 1.21
Effect of beta-hydroxybutyrate on whole-body leucine kinetics and fractional mixed skeletal muscle protein synthesis in humans. J Clin Invest (1988) 1.21
Tumours producing hypoglycaemia. Diabetes Metab Rev (1991) 1.18
Surgeons and HIV. Br Med J (Clin Res Ed) (1988) 1.17
Non-islet cell tumour-associated hypoglycaemia: 111In-octreotide imaging and efficacy of octreotide, growth hormone and glucocorticosteroids. Clin Endocrinol (Oxf) (1996) 1.16
Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells. Cancer Res (1990) 1.15
Investigation of hypoglycaemia. Clin Endocrinol (Oxf) (1996) 1.14
Energy, substrate and protein metabolism in morbid obesity before, during and after massive weight loss. Int J Obes Relat Metab Disord (2000) 1.13
Laparoscopy as an adjunct to decision making in the 'acute abdomen'. Br J Surg (1986) 1.12
Precise measurement of total body water using trace quantities of deuterium oxide. Biomed Mass Spectrom (1977) 1.12
Junctional care: the key to prevention of catheter sepsis in intravenous feeding. JPEN J Parenter Enteral Nutr (1987) 1.11
Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet cell tumour hypoglycaemia. Growth Horm IGF Res (1998) 1.10
Leucine kinetics in surgical patients. II: A study of the effect of malignant disease and tumour burden. Br J Surg (1989) 1.10
Depressed protein synthesis is the dominant characteristic of muscle wasting and cachexia. Clin Physiol (1983) 1.09
Comparison of rubber band ligation and haemorrhoidectomy for second- and third-degree haemorrhoids: a prospective clinical trial. Br J Surg (1980) 1.08
Helicobacter pylori infection in perforated peptic ulcer disease. Br J Surg (1995) 1.08
Leucine kinetics in surgical patients. I: A study of the effect of surgical 'stress'. Br J Surg (1989) 1.06
Acute illness in maple syrup urine disease: dynamics of protein metabolism and implications for management. J Pediatr (1991) 1.06
Regulation of leucine metabolism in man: a stable isotope study. Science (1981) 1.04
Analysis of (1-13C)leucine and (13C)KIC in plasma by capillary gas chromatography/mass spectrometry in protein turnover studies. Biomed Mass Spectrom (1985) 1.04
A comparison of tunnelled and nontunnelled subclavian vein catheters: a prospective study of complications during parenteral feeding. Clin Nutr (1983) 1.04
Role of ineffective erythropoiesis in the anaemia of rheumatoid arthritis. Ann Rheum Dis (1977) 1.03
Comparison of rubber band ligation and sclerosant injection for first and second degree haemorrhoids-- a prospective clinical trial. Acta Chir Scand (1981) 1.03
Changes in fat, fat-free mass and body water in human normal pregnancy. Br J Obstet Gynaecol (1979) 1.03
Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler Thromb (1993) 1.03
Effect of protein source and quantity on protein metabolism in elderly women. Am J Clin Nutr (1998) 1.02
Nitrogen homeostasis in man: the diurnal responses of protein synthesis and degradation and amino acid oxidation to diets with increasing protein intakes. Clin Sci (Lond) (1994) 1.02
Dermoid cyst of the rectum. Dis Colon Rectum (1983) 1.02
Treatment of pilonidal sinus by primary closure with a transposed rhomboid flap compared with deep suturing: a prospective randomised clinical trial. Eur J Surg (1999) 1.00
Mass spectrometric assay of stable isotopic enrichment for the estimation of protein turnover in man. Proc Nutr Soc (1981) 0.99
Reversal of ineffective erythropoiesis in pernicious anaemia following vitamin B12 therapy. Br J Haematol (1977) 0.99
Octreotide exacerbated fasting hypoglycaemia in a patient with a proinsulinoma; the glucostatic importance of pancreatic glucagon. Clin Endocrinol (Oxf) (1995) 0.99
Nitrogen homeostasis in man: influence of protein intake on the amplitude of diurnal cycling of body nitrogen. Clin Sci (Lond) (1994) 0.98
Significant phenylalanine hydroxylation in vivo in patients with classical phenylketonuria. J Clin Invest (1990) 0.97
Sources of ammonia for mammalian urea synthesis. Biochem J (1978) 0.97
The use of stable isotopes for diagnosis and clinical research. Clin Sci (Lond) (1982) 0.97
Radioimmunoassay and saturation analysis. Pharmacology. Br Med Bull (1974) 0.97
Substrate interaction in intravenous feeding: comparative effects of carbohydrate and fat on amino acid utilization in fasting man. Ann Surg (1977) 0.96
Quantitation of ineffective erythropoiesis from the incorporation of [15N] delta-aminolaevulinic acid and [15N] glycin into early labelled bilirubin. II. Anaemic patients. Br J Haematol (1976) 0.95
Effect of intravenous insulin treatment on in vivo whole body leucine kinetics and oxygen consumption in insulin-deprived type I diabetic patients. Metabolism (1987) 0.95
Unusual case of tetrahydrocannabinol intoxication confirmed by radioimmunoassay. Br Med J (1977) 0.95
The Fhit tumor suppressor protein regulates the intracellular concentration of diadenosine triphosphate but not diadenosine tetraphosphate. Cancer Res (2000) 0.95
Antibodies to unconjugated synthetic and natural secretins. Horm Metab Res (1972) 0.94
Genetic testing and screening of individuals at risk of NF2. Clin Genet (2011) 0.94
The use of 13-methyltetradecanoic acid as an indicator of adipose tissue turnover. Lipids (1980) 0.94
The use of metronidazole in management of methylmalonic and propionic acidaemias. Eur J Pediatr (1990) 0.93
Failure of insulin infusion to stimulate fractional muscle protein synthesis in type I diabetic patients. Anabolic effect of insulin and decreased proteolysis. Diabetes (1989) 0.93
Thermic response to isoenergetic protein, carbohydrate or fat meals in lean and obese subjects. Clin Sci (Lond) (1983) 0.93
Incomplete and inaccurate death certification--the impact on research. J Public Health Med (2000) 0.92
Somatomedin-C/insulin-like growth factor-I is a mitogen for human small cell lung cancer. Br J Cancer (1988) 0.92
Radioimmunoassay of vinblastine and vincristine. Br J Clin Pharmacol (1977) 0.92
Total body protein, collagen and non-collagen protein in infantile protein malnutrition. Clin Sci (1966) 0.91
The effect of chronic alcohol ingestion on whole body and muscle protein synthesis--a stable isotope study. Alcohol Alcohol (1991) 0.91
Isotonic biaxial loading of fibroblast-populated collagen gels: a versatile, low-cost system for the study of mechanobiology. Biomech Model Mechanobiol (2002) 0.91
Quantitation of ineffective erythropoiesis from the incorporation of [15N] delta-aminolaevulinic acid and [15N] glycine into early labelled bilirubin. I. Normal subjects. Br J Haematol (1976) 0.91
Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine. J Neurol Neurosurg Psychiatry (1977) 0.91
Hyperglucagonemia during insulin deficiency accelerates protein catabolism. Am J Physiol (1987) 0.91
Influences of dietary energy and protein on leucine kinetics during feeding in healthy adults. Am J Physiol (1996) 0.90
The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer. Int J Cancer (1992) 0.89
Direct determination of leucine metabolism and protein breakdown in humans using L-[1-13C, 15N]-leucine and the forearm model. Eur J Clin Invest (1985) 0.89
Drug-induced hypoglycemia. Endocrinol Metab Clin North Am (1999) 0.89
Radioimmunoassay of bleomycin in plasma and urine. Br J Cancer (1977) 0.88
A case of hepatoma associated with hypoglycaemia and overproduction of IGF-II (E-21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin. Clin Endocrinol (Oxf) (1994) 0.88
Mechanism of muscle wasting in myotonic dystrophy. Ann Neurol (1990) 0.88
Gastric emptying, absorption, and carbohydrate oxidation during prolonged exercise. J Appl Physiol (1985) (1992) 0.88
Oxidation rates of orally ingested carbohydrates during prolonged exercise in men. J Appl Physiol (1985) (1993) 0.88
Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancer. Br J Cancer (1991) 0.88